Search Results

Press Releases

HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500

November 25, 2024

·

4 min read

Press Releases

HemoSonics Awarded Prize from NIH to Expand Use of Quantra Hemostasis System to Help Prevent Maternal Deaths

October 22, 2024

·

4 min read

Bio NC

HemoSonics Named to Fast Company’s 2024 World’s Most Innovative Companies List

HemoSonics, a medical device company focused on acute bleeding management, announced it has been named to the prestigious list of Fast Company’s Most Innovative Companies for 2024.

March 21, 2024

·

4 min read

Bio NC

HemoSonics’ Quantra® Hemostasis System Named as a Finalist in the World Renowned 2024 Edison Awards

HemoSonics, LLC announced that its Quantra Hemostasis System with QPlus® and QStat® Cartridges has been named a finalist in the 2024 Edison™ Awards.

February 13, 2024

·

4 min read

FDA

FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance

HemoSonics, a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its Quantra QStat® Cartridge.

April 3, 2024

·

3 min read

Bio NC

HemoSonics Wins Medical Device Network Excellence Award in Two Categories

HemoSonics announced that the company has won in both the Product Launch and Business Expansion categories in the 2023 Medical Device Network Excellence Awards.

October 5, 2023

·

3 min read

Bio NC

HemoSonics Receives Vizient Innovative Technology Contract for Quantra Hemostasis System

Contract awarded for products that bring improvement to the healthcare industry; HemoSonics’ Quantra Hemostasis System provides comprehensive whole blood coagulation analysis at the point of care in less than 15 minutes

August 3, 2023

·

3 min read

Bio NC

HEMOSONICS AWARDED FDA 510(k) CLEARANCE FOR QUANTRA® HEMOSTASIS SYSTEM WITH QSTAT® CARTRIDGE

HemoSonics, LLC, a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced today that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat Cartridge.

November 30, 2022

·

3 min read

Bio NC

HEMOSONICS APPOINTS DR. BRUCE SPIESS AS MEDICAL DIRECTOR AND EXHIBITS DIAGNOSTIC SOLUTIONS AT ANESTHESIOLOGY®, THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS (ASA) ANNUAL MEETING

Newly appointed Medical Director, Bruce Spiess, MD, FAHA to moderate the educational session “Listening to the Blood: An Update on the Quantra® System, the Latest Technology in the Management of Critical Bleeding”

October 21, 2022

·

4 min read

BioCapital

HemoSonics Welcomes FDA Support of Viscoelastic Coagulation Analyzers for COVID-19 Patients; Highlights the Benefits of the Quantra® Hemostasis Analyzer

HemoSonics Welcomes FDA Support of Viscoelastic Coagulation Analyzers for COVID-19 Patients; Highlights the Benefits of the Quantra ® Hemostasis Analyzer

January 19, 2021

·

5 min read